	US 11,951,146 B2
	Stimulation of NK cell activity by using a combination of broccoli, Nigella Sativa, Green Tea, and pterostilbene alone and together with metformin
Thomas Ichim, Oceanside, CA (US); Timothy G. Dixon, Oceanside, CA (US); Famela Ramos, Oceanside, CA (US); and Wais Kaihani, Oceanside, CA (US)
Assigned to Therapeutic Solutions International, Inc., Oceanside, CA (US)
Filed by Therapeutic Solutions International, Inc., Oceanside, CA (US)
Filed on Nov. 23, 2021, as Appl. No. 17/534,292.
Claims priority of provisional application 63/117,954, filed on Nov. 24, 2020.
Prior Publication US 2022/0160809 A1, May 26, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 36/82 (2006.01); A61K 31/09 (2006.01); A61K 31/122 (2006.01); A61K 31/155 (2006.01); A61K 31/26 (2006.01); A61K 31/352 (2006.01); A61K 36/31 (2006.01); A61K 36/45 (2006.01); A61K 36/71 (2006.01); A61P 31/14 (2006.01); A61P 37/04 (2006.01)

CPC A61K 36/82 (2013.01) [A61K 31/09 (2013.01); A61K 31/122 (2013.01); A61K 31/155 (2013.01); A61K 31/26 (2013.01); A61K 31/352 (2013.01); A61K 36/31 (2013.01); A61K 36/45 (2013.01); A61K 36/71 (2013.01); A61P 37/04 (2018.01)]

16 Claims

1. A method of augmenting natural killer cell activity in a mammal suffering from COVID-19, comprising administration to said mammal a therapeutic combination comprising of: a) Green Tea and/or extract thereof; b) Blueberry and/or extract thereof; c) Nigella sativa and/or extract thereof; d) broccoli and/or extract thereof and e) metformin.